日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The real-world analysis of adverse events with teduglutide: a pharmacovigilance study based on the FAERS database

基于FAERS数据库的药物警戒研究:特度格鲁肽不良事件的真实世界分析

Wang, Xiaogan; Chen, Hao; Han, Shuangshuang; Li, Lingbo; Chen, Hongjin; Yang, Bolin

Different situations of identifying second primary malignant tumors in lymphoma patients with synchronous solid tumors

淋巴瘤合并同步实体瘤患者中第二原发恶性肿瘤的识别情况

Gao, Hongye; Wang, Xiaogan; Lai, Yumei; Zhang, Chen; Mi, Lan; Ji, Xinqiang; Wang, Xiaopei; Song, Yuqin; Zhu, Jun; Liu, Weiping

Ibrutinib combined with low-dose histone deacetylases inhibitor chidamide synergistically enhances the anti-tumor effect in B-cell lymphoma

伊布替尼联合低剂量组蛋白去乙酰化酶抑制剂西达本胺可协同增强B细胞淋巴瘤的抗肿瘤作用

Hui Yu, Lan Mi, Weimin Zhang, Yingying Ye, Miaomiao Li, Dingyao Hu, Jiaowu Cao, Dedao Wang, Xiaogan Wang, Ning Ding, Yuqin Song, Jun Zhu

EP300 single nucleotide polymorphism rs20551 correlates with prolonged overall survival in diffuse large B cell lymphoma patients treated with R-CHOP.

EP300 单核苷酸多态性 rs20551 与接受 R-CHOP 治疗的弥漫性大 B 细胞淋巴瘤患者的总生存期延长相关

Li Jiao, Ding Ning, Wang Xiaogan, Mi Lan, Ping Lingyan, Jin Xuan, Liu Yalu, Ying Zhitao, Xie Yan, Liu Weiping, Song Yuqin, Zhu Jun

TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP

TP53 Arg72 是接受 CHOP 方案治疗的中国弥漫性大 B 细胞淋巴瘤患者的有利预后因素

Liu, Yalu; Wang, Xiaogan; Ding, Ning; Mi, Lan; Ping, Lingyan; Jin, Xuan; Li, Jiao; Xie, Yan; Ying, Zhitao; Liu, Weiping; Zhang, Chen; Deng, Lijuan; Song, Yuqin; Zhu, Jun

CD275-Independent IL-17-Producing T Follicular Helper-like Cells in Lymphopenic Autoimmune-Prone Mice

淋巴细胞减少的自身免疫易感小鼠体内不依赖于CD275的IL-17产生型滤泡辅助性T细胞样细胞

Smith, Christopher; Buhlmann, Janet E; Wang, Xiaogan; Bartlett, Amber; Lim, Bing; Barrington, Robert A